The Munich-based holding company has spent much of 2026 under a cloud of skepticism, but a string of concrete developments is starting to shift the narrative. Shares in Mutares edged up 3.11% to €28.15 on Thursday, reflecting renewed confidence that management is finally delivering the exits investors have been waiting for. Yet the stock remains more than 5% down year-to-date and still trades 23% below its 52-week high of €36.75, suggesting the market is demanding further proof.
That proof is building on multiple fronts. The headline catalyst is the signing on June 10, 2026 of the sale of NEM Energy Group to South Korea’s Hyundai Heavy Industries Power Systems. Mutares acquired the heat-transfer specialist from Siemens Energy just four years ago, in 2022, underscoring how quickly the firm can create value. While no official price tag was disclosed, market estimates put the net proceeds at roughly €100 million. That sum alone would cover a large chunk of the group’s full-year holding profit target of €165 million to €200 million. The deal is expected to close in the third quarter.
Meanwhile, the pipeline for further disposals remains rich. Chief Investment Officer Johannes Laumann has flagged a well-stocked exit queue that includes the fire-engine maker Magirus, steel specialist Donges, and the EFACEC stake. Magirus has become a particularly potent asset: its order book has ballooned past €880 million, a record, and Mutares is exploring both a sale and an initial public offering. The unit gained additional appeal last autumn when Mutares acquired Achleitner Fahrzeugbau and rebranded it as Magirus Defense Systems, adding a military dimension. Analyst estimates put the potential enterprise value of EFACEC at €300 million to €420 million, making it another high-impact candidate.
Should investors sell immediately? Or is it worth buying Mutares?
Management is also tidying up the portfolio in smaller steps. The partial sale of the Benelux distribution arm of the truck-crane business F.lli Ferrari to HMF Group has a revenue volume of around €35 million and fits into a broader cleanup campaign. At the same time, Mutares is strengthening its balance sheet with a bond buyback program that channels at least €25 million per quarter into the market. At end-2025, €385 million of outstanding bonds remained. The buyback is trimming interest expenses, though the stock market has yet to applaud the move.
Technically, the shares are approaching a critical juncture. They now stand 6.23% above their 50-day moving average of €26.50 and have narrowed the gap to the 200-day line at €29.01 to just 3%. The relative strength index of 57.5 is constructive without signaling overbought conditions. A clean break above the 200-day average would open the door to a recovery toward the analyst target range of €34 to €48. But the stock’s annualized volatility of 22.40% remains a structural feature of this private-equity model.
All eyes will be on the annual general meeting on July 3 in Munich, where management will propose a base dividend of €2.00 per share. An additional performance-linked payout is also on the table if lucrative disposals go through. For the current year, Mutares expects group revenue to approach €9 billion, while the net profit range of €165 million to €200 million already looks more achievable thanks to the NEM sale. The risk of equity dilution has receded amid strong cash generation, but the real test will be whether further exits—especially from Magirus and EFACEC—materialize in the coming quarters to close the valuation gap.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from June 11 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 11.
Mutares: Buy or sell? Read more here...










